Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

616 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Artificial intelligence for target prostate biopsy outcomes prediction the potential application of fuzzy logic.
Checcucci E, Rosati S, De Cillis S, Vagni M, Giordano N, Piana A, Granato S, Amparore D, De Luca S, Fiori C, Balestra G, Porpiglia F. Checcucci E, et al. Among authors: de cillis s, de luca s. Prostate Cancer Prostatic Dis. 2022 Feb;25(2):359-362. doi: 10.1038/s41391-021-00441-1. Epub 2021 Sep 3. Prostate Cancer Prostatic Dis. 2022. PMID: 34480083 Free PMC article.
Development of a novel nomogram to identify the candidate to extended pelvic lymph node dissection in patients who underwent mpMRI and target biopsy only.
Fiori C, Checcucci E, Stura I, Amparore D, De Cillis S, Piana A, Granato S, Volpi G, Sica M, Piramide F, Verri P, Manfredi M, De Luca S, Autorino R, Migliaretti G, Porpiglia F. Fiori C, et al. Among authors: de cillis s, de luca s. Prostate Cancer Prostatic Dis. 2023 Jun;26(2):388-394. doi: 10.1038/s41391-022-00565-y. Epub 2022 Jun 24. Prostate Cancer Prostatic Dis. 2023. PMID: 35750851
Diagnostic Accuracy of Single-plane Biparametric and Multiparametric Magnetic Resonance Imaging in Prostate Cancer: A Randomized Noninferiority Trial in Biopsy-naïve Men.
Russo F, Mazzetti S, Regge D, Ambrosini I, Giannini V, Manfredi M, De Luca S, Bollito E, Porpiglia F. Russo F, et al. Among authors: de luca s. Eur Urol Oncol. 2021 Dec;4(6):855-862. doi: 10.1016/j.euo.2021.03.007. Epub 2021 Apr 21. Eur Urol Oncol. 2021. PMID: 33893066 Clinical Trial.
The real-time intraoperative guidance of the new HIFU Focal-One® platform allows to minimize the perioperative adverse events in salvage setting.
Checcucci E, De Luca S, Piramide F, Garrou D, Mosca A, Galla A, Belli G, Russo F, Rescigno P, Poti C, Amparore D, Verri P, Volpi G, Manfredi M, Fiori C, Porpiglia F. Checcucci E, et al. Among authors: de luca s. J Ultrasound. 2022 Jun;25(2):225-232. doi: 10.1007/s40477-021-00594-8. Epub 2021 May 24. J Ultrasound. 2022. PMID: 34031862 Free PMC article.
New Ultra-minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia: A Systematic Review and Analysis of Comparative Outcomes.
Checcucci E, Veccia A, De Cillis S, Piramide F, Volpi G, Amparore D, Pecoraro A, Piana A, Granato S, Verri P, Sica M, Meziere J, Carbonaro B, Piscitello S, Zamengo D, Cacciamani G, Okhunov Z, Puliatti S, Taratkin M, Marenco J, Gomez Rivas J, Veneziano D, Carbonara U, Russo GI, De Luca S, Manfredi M, Fiori C, Autorino R, Porpiglia F; Uro-technology and SoMe Working Group of the Young Academic Urologists Working Party of the European Association of Urology and of the Lower Tract and Research Group of the European Section of Uro-technology. Checcucci E, et al. Among authors: de cillis s, de luca s. Eur Urol Open Sci. 2021 Sep 22;33:28-41. doi: 10.1016/j.euros.2021.08.009. eCollection 2021 Nov. Eur Urol Open Sci. 2021. PMID: 34604814 Free PMC article. Review.
Reply to Anwar R. Padhani, Ivo G. Schoots, Jelle O. Barentsz. Fast Magnetic Resonance Imaging as a Viable Method for Directing the Prostate Cancer Diagnostic Pathway. Eur Urol Oncol 2021;4:863-5: Fast-MRI Feasibility in Biopsy-naïve Patients: Clarifications on the Study Methods and Results.
Russo F, Mazzetti S, Regge D, Ambrosini I, Giannini V, Manfredi M, De Luca S, Bollito E, Porpiglia F. Russo F, et al. Among authors: de luca s. Eur Urol Oncol. 2021 Dec;4(6):866-867. doi: 10.1016/j.euo.2021.06.005. Epub 2021 Jul 24. Eur Urol Oncol. 2021. PMID: 34315690 No abstract available.
The waiting time for prostate cancer treatment in Italy: analysis from the PROS-IT CNR Study.
Gacci M, Greco I, Artibani W, Bassi P, Bertoni F, Bracarda S, Briganti A, Carmignani G, Carmignani L, Conti GN, Corvò R, DE Nunzio C, Fusco F, Graziotti P, Maggi S, Magrini SM, Mirone V, Montironi R, Muto G, Noale M, Pecoraro S, Porreca A, Ricardi U, Russi E, Salonia A, Simonato A, Serni S, Tubaro A, Zagonel V, Crepaldi G; Pros-IT CNR Study Group. Gacci M, et al. Among authors: de nunzio c. Minerva Urol Nephrol. 2022 Feb;74(1):38-48. doi: 10.23736/S2724-6051.20.03925-9. Epub 2020 Nov 17. Minerva Urol Nephrol. 2022. PMID: 33200896 Free article.
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study.
Gacci M, Artibani W, Bassi P, Bertoni F, Bracarda S, Briganti A, Carmignani G, Carmignani L, Conti G, Corvò R, De Nunzio C, Fusco F, Graziotti P, Greco I, Maggi S, Magrini SM, Mirone V, Montironi R, Morgia G, Muto G, Noale M, Pecoraro S, Porreca A, Ricardi U, Russi E, Russo G, Salonia A, Simonato A, Serni S, Tomasini D, Tubaro A, Zagonel V, Crepaldi G; MIRROR-SIU/LUNA Study Group and the Pros-IT CNR Study Group. Gacci M, et al. Among authors: de nunzio c. World J Urol. 2021 May;39(5):1445-1452. doi: 10.1007/s00345-020-03350-5. Epub 2020 Aug 1. World J Urol. 2021. PMID: 32740803
[Prostate biopsy: staging values].
De Luca S, Bertaccini A, Galetti TP; Gruppo Italiano Biopsia Prostatica. De Luca S, et al. Arch Ital Urol Androl. 2005 Sep;77(3 Suppl 1):57-62. Arch Ital Urol Androl. 2005. PMID: 16402732 Review. Italian. No abstract available.
616 results